Allergan Inc $162.76

down -1.21


27/8/2014 04:01 PM  |  NYSE : AGN  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get AGN Trend Analysis - it has outperformed the S&P 500 by 63%

Partner Headlines

  1. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  2. S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue ...

    Benzinga
  3. 3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology

    Benzinga
  4. Yellen's Speech Not Enough To Keep Dow, S&P 500 In Positive Territory

    Benzinga
  5. S&P 500 Marks New High As Indexes Hold Gains

    IBD
  6. SALIX PHARMACEUTICALS

    IBD
  7. Major Indexes Turn Mixed; Jazz Pharmaceuticals Turns Up

    IBD
  8. Benzinga's M&A Chatter for Tuesday August 19, 2014

    Benzinga
  9. Salix Soars On Allergan Buzz

    IBD
  10. Indexes Rally On Strong Housing Data, Retail Reports

    IBD
  11. Dow Flirts With 19,000, S&P 500 Approaches 2,000 & Nasdaq Trading At 14-Year ...

    Benzinga
  12. Stocks Add To Gains; Salix Surges On Potential Bid

    IBD
  13. Allergan Reportedly Eyes Salix To Avoid Valeant Deal

    IBD
  14. Allergan On The Acquisition Hunt

    Benzinga
  15. JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And ...

    Benzinga
  16. Allergan

    IBD
  17. Allergan Takes In 13 New Hedge Fund Investments In Q2

    Benzinga
  18. Notable Hedge Funds Disclose Additions And Reductions To Holdings

    Benzinga
  19. Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension ...

    Benzinga
  20. Benzinga's M&A Chatter for Monday August 11, 2014

    Benzinga
  21. Valeant Pharmaceuticals'

    IBD
  22. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  23. Allergan

    IBD
  24. Allergan Rebounds After Analyst Upgrades On Valuation

    IBD
  25. Benzinga's Top Upgrades

    Benzinga
  26. Leerink Swann Upgrades Allergan To Outperform

    Benzinga
  27. Fast Money Picks For August 8

    Benzinga
  28. Top Performing Funds Play Favorits

    IBD
  29. Prescription Drugmakers Slide Down Industry Rankings

    IBD
  30. Thursday's Selling Momentum Continues In To Friday

    Benzinga
  31. Thursday's Selling Momentum Continues Into Friday

    Benzinga
  32. US M&A Announced Deals Surpass $1 Trillion For 2014

    Benzinga
  33. Valeant, Ackman's Pershing Square Issue Response to 'Frivolous Allergan ...

    Benzinga
  34. Valeant Guides Outlook Low

    IBD
  35. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  36. Valeant Q2 Meets Views; Guidance Down On Asset Sale

    IBD
  37. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  38. George Soros Reveals His Largest Stake

    GuruFocus
  39. Earnings Season Boosts Confidence; S&P Trades At Record Highs

    Benzinga
  40. BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share

    Benzinga
  41. UPDATE: UBS Securities Upgrades Allergan On Conference Call Takeaways

    Benzinga
  42. Allergan EPS Gains Accelerate

    IBD
  43. Allergan Earnings Growth, Job Cuts Counter Valeant

    IBD
  44. UPDATE: Allergan Posts Upbeat Q2 Earnings, Plans To lower 13% Of Workforce

    Benzinga
  45. Allergan to Slash 13% of its Global Workforce

    FoxBusiness
  46. UPDATE: Valeant Complains to SEC Regarding Allergan Claims

    Benzinga
  47. Earnings Scheduled For July 21, 2014

    Benzinga
  48. Stocks To Watch For July 21, 2014

    Benzinga
  49. Pershing Square Releases Letter To Allergan's Board Of Directors, Fund ...

    Benzinga
  50. Valeant Submits HSR Filing Related to Proposed Allergan Deal

    Benzinga
Trading Center